Objective: To assess the safety profile of acarbose treatment over a 1-year period at a dose range of 50 300mg three times daily in patients with type 1 or type 2 diabetes mellitus. Results ...

Objective and design: This post-marketing surveillance study collected data on the efficacy and tolerability of acarbose in patients with insulin-treated type 2 diabetes mellitus and, in ...

DelveInsight’s “Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an ...

China: Recent observations have highlighted a rare and noteworthy side effect associated with the use of glucagon-like ...

Getting prescriptions for certain types of drugs — such as ketamine for mental health, or semaglutides for weight loss — can sometimes come with unnecessary judgement. But telehealth providers like ...

However, its acute glucose lowering effect is comparable to other diabetic medications like Acarbose and Nateglinide. This ...